6137 results for "canc*"
in 28.00 milliseconds.
-
AA/UTUC Cancer Data Access Commitee
Dac EGAC00001002162 -
MRC Institute of Genetics and Cancer Data Access Committee
Dac EGAC00001002163 -
University of Calgary Charbonneau Cancer Institute
Dac EGAC00001002170 -
The data access committee for Detection and characterization of lung cancer using cell-free DNA fragmentomes
Dac EGAC00001002184 -
TCRseq in cancers DAC
Dac EGAC00001002235 -
Cancer Proteomics Mass Spectrometry group
Dac EGAC00001002236 -
CRMY team data access committee
Dac EGAC00001002249 -
The MITIMM Cancer Data Access Committee
Dac EGAC00001002268 -
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer
Dac EGAC00001002276 -
Data access committee breast cancer whole genome sequencing HRD
Dac EGAC00001002286 -
Breast Cancer Single-Cell Data Access Committee
Dac EGAC00001002291 -
Genomics to select patients with metastatic breast cancer for targeted therapy DAC
Dac EGAC00001002293 -
RNA-sequencing of tumors from 45 patients with recurrent or metastatic gastric cancer treated with immune checkpoint inhibitors
Dac EGAC00001002295 -
EPICC: Evolutionary Predictions in Colorectal Cancer
Dac EGAC00001002299 -
OV cancer cell lines DAC
Dac EGAC00001002307 -
Division of Molecular Oncology, National Cancer Center Research Institute Data Access Committee
Dac EGAC00001002331 -
MDACC Breast Cancer MoonShot Data Access Committee
Dac EGAC00001002362 -
Lung cancer cfDNA dataset DAC
Dac EGAC00001002387 -
Lung cancer cfDNA dataset DAC
Dac EGAC00001002388 -
Somatic pathogenic variants in the normal mammary gland of sporadic breast cancer patients.
Dac EGAC00001002391 -
Leeds institute of Medical Research Bladder Cancer Research Group
Dac EGAC00001002397 -
Cancer Clinical Research Trust DAC for the 23 WES samples of melanoma subtypes
Dac EGAC00001002402 -
Cancer Team Data Access Committee
Dac EGAC00001002449 -
University of Melbourne Centre for Cancer Research (UMCCR) Data Access Committee
Dac EGAC00001002442 -
Netherlands Cancer Institute - Breast Cancer Neoadjuvant chemotherapy biomarker studies
Dac EGAC00001002452